electroCore, Inc. (ECOR) NASDAQ
9.63
-0.72(-6.96%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.63
-0.72(-6.96%)
Currency In USD
Address
200 Forge Way
Rockaway, NJ 07866
United States of America (the)
Phone
973 290 0097
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
73
First IPO Date
June 22, 2018
| Name | Title | Pay | Year Born |
| Thomas J. Errico | Founder & Independent Chairman | 75,000 | 1953 |
| Peter S. Staats | Chief Medical Officer | 238,415 | 1964 |
| Joshua S. Lev | CFO & Interim President | 528,900 | 1985 |
| Amanda Yanuklis | Chief of Staff | 0 | N/A |
| Andy Brown | Vice President & Corporate Controller | 0 | N/A |
| Mitch Deshon | Vice President of Sales & New Market Development | 0 | N/A |
| Jennifer A. Hayes | Vice President of HR & Employee Success | 0 | N/A |
| Manuel A. Marques | Senior Vice President of Operations | 0 | 1973 |
| Michael Fox | Chief Operating Officer | 0 | N/A |
| Donald Melnikoff | Senior Vice President of Engineering, Regulatory & Compliance | 0 | N/A |
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.